Market research
INDRAMEDCO.NSE Indraprastha Medical Corporation Limited
NSE INR Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 27B
- P/E ratio
- 14.62
- Analyst target
- 550
- Dividend yield
- 0.0%
- Beta
- 0.43
Profile
Instrument facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- INE681B01017
- Market cap
- 27B
- P/E ratio
- 14.62
- Analyst target
- 550
- Dividend yield
- 0.0%
- Beta
- 0.43
About
About Indraprastha Medical Corporation Limited
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of genomic medicine, internal medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic and cosmetic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency care, gastroenterology, neurology/neurosurgery, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.
Research context
Indraprastha Medical Corporation Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the INDRAMEDCO.NSE discussion.
5 years, 6 months ago
Indraprastha Medical Corporation Limited is currently in a long term uptrend where the price is trading 31.7% above its 200 day moving average.
From a valuation standpoint, the stock is 81.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Indraprastha Medical Corporation Limited's total revenue sank by 14.5% to $2B since the same quarter in the previous year.
Its net income has increased by 12.2% to $120M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $56M since the same quarter in the previous year.
Based on the above factors, Indraprastha Medical Corporation Limited gets an overall score of 3/5.